The vitamin B complex consists of eight distinct vitamins that function as cofactors for the enzymes of one-carbon metabolism — the network of biochemical reactions that transfer methyl groups (one-carbon units) between molecules, and which is fundamentally involved in the synthesis, repair, and methylation of DNA, the metabolism of homocysteine, the synthesis of neurotransmitters, and the formation of the methyl groups that are essential for the function of virtually every cell in the body. The eight B vitamins — thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B3), biotin (B7), folate (B9), and cobalamin (B12) — each play a specific and irreplaceable role in one-carbon metabolism, and deficiency in any one of them disrupts the entire network, producing a characteristic pattern of clinical manifestations that includes elevated homocysteine (a risk factor for cardiovascular disease and cognitive decline), impaired DNA synthesis and repair (contributing to anaemia and immunocompromise), and disturbed neurotransmitter metabolism (contributing to depression, anxiety, and cognitive impairment).
One-Carbon Metabolism and the Methylation Cycle
One-carbon metabolism consists of two interconnected cycles: the folate cycle and the methionine cycle. The folate cycle begins with dietary folate (folic acid or 5-methyltetrahydrofolate, 5-MTHF) and proceeds through a series of enzyme-catalysed reactions that generate the one-carbon units necessary for the synthesis of purines (adenine and guanine, the building blocks of DNA and RNA), the methylation of DNA and histone proteins, and the conversion of homocysteine to methionine. The methionine cycle generates S-adenosylmethionine (SAM), the universal methyl donor for over 100 methyltransferases in the body, which methylate DNA, RNA, proteins, lipids, and neurotransmitters. The intersection of these two cycles occurs at the enzyme methionine synthase (MS), which requires both folate (as 5-methyltetrahydrofolate) and vitamin B12 (as methylcobalamin) as cofactors to convert homocysteine to methionine. When either folate or B12 is deficient, homocysteine accumulates — a condition called hyperhomocysteinaemia, which is an independent risk factor for cardiovascular disease, venous thromboembolism, cognitive impairment, and Alzheimer disease.
Each B vitamin plays a specific and irreplaceable role in this system. Thiamine (B1) is the cofactor for pyruvate dehydrogenase and transketolase — enzymes that link glycolysis to the pentose phosphate pathway and to the TCA cycle. Riboflavin (B2, as FAD and FMN) is the cofactor for the enzyme MTHFR (methylenetetrahydrofolate reductase), which generates the 5,10-methylenetetrahydrofolate substrate used for the synthesis of purines and for the methylation of homocysteine to methionine. Niacin (B3, as NAD and NADP) is the cofactor for the enzymes of the poly ADP-ribosylation reactions involved in DNA repair and for the reductases that generate the NADPH required for the synthesis of fatty acids and steroids. Pantothenic acid (B5, as CoA) is the cofactor for the acyltransferases of the TCA cycle and for the enzymes of fatty acid synthesis. Pyridoxine (B6, as pyridoxal phosphate, PLP) is the cofactor for the transaminases of amino acid metabolism, for the enzymes of neurotransmitter synthesis (including the synthesis of dopamine, serotonin, and GABA), and for the enzymes of haem synthesis. Biotin (B7) is the cofactor for the carboxylases of fatty acid synthesis and for the enzymes of gluconeogenesis. Folate (B9) is the methyl donor for the folate cycle and is essential for the synthesis of purines and for the methylation of homocysteine to methionine. Cobalamin (B12) is the cofactor for methionine synthase (which converts homocysteine to methionine) and for methylmalonyl-CoA mutase (which converts methylmalonyl-CoA to succinyl-CoA in the TCA cycle).
Homocysteine and Cardiovascular Risk
Elevated homocysteine (hyperhomocysteinaemia) is an independent risk factor for cardiovascular disease, stroke, and venous thromboembolism. The mechanism by which homocysteine damages blood vessels involves the endothelial dysfunction produced by homocysteine — it inhibits the synthesis of nitric oxide, increases the production of reactive oxygen species (including the superoxide radical, which reacts with nitric oxide to form the damaging peroxynitrite), activates the NF-kappaB inflammatory pathway, and promotes the oxidation of LDL cholesterol. A meta-analysis of 40 prospective cohort studies found that elevated homocysteine was associated with approximately 60-70% increased risk of coronary heart disease and stroke, independent of traditional cardiovascular risk factors. The relationship is dose-dependent — each 5 micromol/L increase in fasting homocysteine is associated with approximately 20% increased cardiovascular risk. Importantly, the relationship between homocysteine and cardiovascular risk is modifiable: B vitamin supplementation (particularly with folate, B12, and B6) consistently lowers homocysteine levels, and the combination of these three B vitamins is the standard clinical treatment for hyperhomocysteinaemia.
B Vitamins and Cognitive Function
The B vitamins are essential for cognitive function through their role in neurotransmitter synthesis and in the maintenance of homocysteine at safe levels. The synthesis of the key neurotransmitters dopamine, serotonin, and noradrenaline requires folate and B12 as methyl donors (for the methylation reactions that synthesise these neurotransmitters from their amino acid precursors), B6 as a cofactor (for the decarboxylation and transamination reactions in neurotransmitter synthesis), and B1 and B2 as cofactors (for the energy metabolism of the neurons that use these neurotransmitters). Deficiencies in any of these B vitamins can impair neurotransmitter synthesis and produce the depression, anxiety, and cognitive impairment that characterise B vitamin deficiency states. The homocysteine connection to cognitive function is equally important: elevated homocysteine is associated with a 2-3 fold increased risk of Alzheimer disease and vascular dementia, and B vitamin supplementation that lowers homocysteine has been shown to slow the rate of brain atrophy in subjects with mild cognitive impairment.
Practical Application
For comprehensive methylation support and homocysteine management, a B-complex supplement that includes all eight B vitamins in their active forms is the most appropriate choice. The key forms are folate as 5-methyltetrahydrofolate (5-MTHF, the active form that does not require MTHFR conversion) rather than folic acid (the synthetic form that is poorly converted in people with MTHFR polymorphisms), B12 as methylcobalamin or hydroxycobalamin (rather than cyanocobalamin, which is less well-retained), and B6 as pyridoxal-5-phosphate (PLP, the active coenzyme form) rather than pyridoxine (which is the less bioactive form). For homocysteine management specifically, the evidence-based combination is folate (as 5-MTHF at 400-800mcg), B12 (as methylcobalamin at 500-1,000mcg), and B6 (as PLP at 10-25mg), which effectively lowers homocysteine in the majority of individuals. For comprehensive neurological and cognitive support, this B-complex combination can be combined with the omega-3 fatty acids (which support membrane composition and reduce neuroinflammation) and with alpha-GPC (which provides choline for acetylcholine synthesis).
Leave a Reply